Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-22-007860

Chief Financial Officer acquired 24,336 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Byrne Jason · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-08 Exercise or conversion : show line 1 in the form +24,336 $4.11 $100,021 24,336 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-08 Exercise or conversion : show line 2 in the form Option to purchase Common Stock −24,336 412,865 D
Loading xslF345X03/doc4.xml…